Clinical Trials Browser

Phase 3 × Withdrawn × Blood Specimen Collection × Clear all

NCT02100618 2015-07-20

Antibody Persistence for GlaxoSmithKline (GSK) Biologicals' HPV-16/18 L1 VLP AS04 Vaccine (GSK-580299) Administered in Healthy Adults and Adolescents, 6.5 Years After First Vaccination in the Primary Study

Phase 3 Withdrawn

Papillomavirus Infections

NCT01209013 2012-05-08

Oedisse

Phase 3 Withdrawn

Gastrointestinal

Barrett Esophagus